Pfizer’s Drug Combo Prolongs Lives in Advanced Prostate Cancer Patients
Pfizer’s Talzenna-Xtandi combination has marked a major step forward in treating advanced prostate cancer, improving patient outcomes and survival.
Pfizer’s Talzenna-Xtandi combination has marked a major step forward in treating advanced prostate cancer, improving patient outcomes and survival.
© 2023 Arise News - Part of the Arise Media Group.